Drug Type Small molecule drug |
Synonyms Claritin/Singulair, Loratadine/montelukast, Montelukast/loratadine |
Target |
Mechanism CysLT1 antagonists(Cysteinyl leukotriene receptor 1 antagonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Molecular FormulaC35H36ClNNaO3S |
InChIKeyZMFQNQCXWQXCFO-HKHDRNBDSA-N |
CAS Registry151767-02-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rhinitis, Allergic, Seasonal | NDA/BLA | - | - | |
Rhinitis, Allergic, Seasonal | NDA/BLA | US | - |
Phase 3 | 69 | (Montelukast 10 mg/Loratadine 10 mg) | fgtljvvjhl(ftuylsdnyb) = ejozlmxusm odxjkcgleg (rcogadmsrx, hucrwyvlau - czczgqexwt) View more | - | 14 Nov 2014 | ||
Placebo (Placebo) | fgtljvvjhl(ftuylsdnyb) = nwwlmygodv odxjkcgleg (rcogadmsrx, aoufcmcdpn - hamyplawbw) View more |